Informationen:
Fehler:
ID
34263
Beschreibung
Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies; ODM derived from: https://clinicaltrials.gov/show/NCT01251757
Link
https://clinicaltrials.gov/show/NCT01251757
Stichworte
Versionen (1)
- 16.01.19 16.01.19 -
Rechteinhaber
see on clinicaltrials.gov
Hochgeladen am
16. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Diabetes Mellitus NCT01251757
Eligibility Diabetes Mellitus NCT01251757
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Diabetes Mellitus NCT01251757
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
ID.1
Item
aged 40-80 years as of time of randomization.
boolean
ID.2
Item
two or more medication dispensings for any prescription medication from a kp outpatient pharmacy during the baseline year.
boolean
ID.3
Item
flagged in kp's databases as having either diabetes or atherosclerotic cardiovascular disease(defined as coronary artery disease, peripheral vascular disease, or a history of atherosclerotic stroke)
boolean
ID.4
Item
continuous membership in kp for the 12 months prior to randomization.
boolean
ID.5
Item
willing to participate in the study.
boolean
ID.6
Item
evidence in the emr of allergy or intolerance to statins, ace inhibitors/arbs,or aspirin
boolean
ID.7
Item
use of warfarin or other antiplatelet agents for which aspirin use is contraindicated
boolean
ID.8
Item
end-stage renal disease or other conditions for which ace inhibitor or arb use is contraindicated
boolean
ID.9
Item
use of medications for which use of statins is contraindicated
boolean